Chris Cain

In his role at Hyalex, Chris has global responsibility for all aspects of clinical research and regulatory affairs for the HYALEX Cartilage System. Prior to joining Hyalex, Chris was VP of Clinical and Regulatory Affairs for Devoro, Inc. (acquired by Boston Scientific), Conformal Medical, Inc., and Corindus Vascular Robotics (acquired by Siemens) In his previous roles, he was responsible for global clinical activities supporting regulatory marketing clearances and approvals and clinical evidence generation contributing to the companies’ publication portfolios. He also led global regulatory strategy resulting in marketing clearances/approvals worldwide. He earned a B.S. in Nursing from the University of Central Missouri and an MBA from University of Missouri Kansas City. In his free time, he enjoys traveling, hiking, and skiing.